chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I woke at 1:30am, 12 hours after my shot, with a severe headache and nausea. I felt dizzy and weak. I did not take my temperature because I felt too sick to look for the thermometer. I took 2 ibuprofin but it didn't help. Symptoms lessened over the next 12 hours but did not go away for 2 days. After that, I  felt foggy and unfocused. For weeks I noticed a  marked increase of incidents where I could not rem- ember famillar words.    (see next page) For example, I tried to say to my husband while out  on a walk " Look at that birdhouse," but I could not remember the word " birdhouse" I tried to call it " birdbox" and " birdhome." This was 3 weeks after my shot. I also had several occasions while driving, of suddenly not knowing where I was for several moments, before finally realizing I was actually on a familiar route- in broad daylight. This happened rarely in the past and only at night. It is over 7 months later and I am still having these incidents of forgetting familiar information. This rarely happened to me before I got COVID vaccine. I do not want to get any more COVID 19 shots. I fear they may cause me to become unable to work because I may forget all the many details I need to remember to do my job as a personal care aide for 2 clients-
Developed redness and swelling on Left deltoid. Developed a headache on the morning of 02/02/12.
Vaccinated 8/9 in afternoon; sore achy arm at site; difficulty lifting arm above shoulder.  Developed fever (101 °F) and headache 8/10 in afternoon & went to bed early. Fever broke by midnight. Began breaking out in hives on 8/11; hives merged into uniform red-hot rash, neck to feet on 8/12, Hives began fading 8/13 and were gone by 1 week. Skin began peeling about 3 weeks later, similar to sunburn.
PATIENT HAD BEEN VACCINATED ON MORNING OF 5/13/2019. THAT EVENING ABOUT 4PM SHE FELT FLU LIKE SYMPTOMS AND SEVERE CHILLS AND ARM VERY SORE WITH A BUMP. THE NEXT MORNING AFTER TAKING SOME ADVIL PATIENT REPORTED FEELING BETTER BUT ARM STILL VERY SORE AND LUMP STILL PRESENT. THAT EVENING(5/14/19) ABOUT 6PM SHE NOTICED 2 POCK LIKE SPOTS RIGHT SIDE OF HER NAVEL THAT WERE CRUSTED OVER. SHE CALLED US AND HER PHYSICIAN.  SHE WAS SEEN BY NP WHO DIAGNOSED IT AS SHINGLES AND PRESCRIPBED VALTREX 1GM TO BE TAKEN 3 TIMES DAILY FOR 7 DAYS
pt recvd vax & w/in 10 to 15 mins p/vax pt turned blue & stopped breathing; pt was dx w/anaphylactic react; no further details were provided;
she started period again; highly upset; scared; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 60-year-old female patient received BNT162b2 (BNT162B2), as dose number unknow, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: POSTMENOPAUSAL HAEMORRHAGE (medically significant), outcome "unknown", described as "she started period again"; EMOTIONAL DISTRESS (non-serious), outcome "unknown", described as "highly upset"; FEAR (non-serious), outcome "unknown", described as "scared".  Clinical course: Reporter stated, "For this case no because I called may be 6 months ago because one of my girlfriend gone through menopause got Pfizer shot and she was scared to call so I called for she started period again. She's 60 years old haven't had period like 7 years so she was highly upset and scared, and I called then you know before on that."  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Around 4:30 pm client noted swelling to (R) eye. Continued to get worse so the she went to the local emergency room. Was given prednisone by ER doctor.
She received two doses of Moderna Vaccine given at an event center and no one identified that she was too young to receive the vaccine. No adverse reaction according to her father.
LUNGS ARE CLEAR AND MUCH BETTER; This spontaneous report received from a patient concerned a 62 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included chronic obstructive pulmonary disease.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 200A2/A OR 206A2/A, and batch number: 200A2/A OR 206A2/A expiry: UNKNOWN) dose was not reported, administered on 04-MAY-2021 for prophylactic vacccination. No concomitant medications were reported. On an unspecified date, the subject experienced lungs are clear and much better. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from lungs are clear and much better. This report was non-serious.
Temp 103. 5 max persisted into 4th day with 10 cm area of erythema edema & pain (R) thigh at PNEUMOVAX inj site. 2 cm erythema at meningococcal site.
Narrative:  COVID infection following COVID vaccine series 03/18, Pfizer, dose #1 04/08, Pfizer, dose #2 08/12 pt cc: has dementia exposure: unknown 08/12 pt admit to Medicine dx :Acute Hypoxic Respiratory Failure due to COVID-19 Infection LOC: 18 08/13 - 08/26 pt symptoms continue 08/12 TROPONIN I result: 0.036 08/12 COVID swab, result: detected 08/12 BNP result: 506.6 08/12 CK CREATINE KINASE result: 382.0 08/12 TROPONIN I result: 0.078 08/12 CXR impression: No acute cardiopulmonary abnormality or change since 6/3/2021. 08/13 DDIMER result: 2.11 08/13 CTA PE impression: . No pulmonary embolus to the subsegmental level. 2. Thick-walled central bronchi could reflect ongoing bronchitis. This may account for the patient's hypoxemia and might be secondary to ongoing COVID. Centrilobular groundglass opacities in the RUL and LLL may reflect ongoing/developing COVID pneumonitis. 08/14 ESR result: 21 08/15 CXR impression: No acute cardiopulmonary disease 08/19 ABG i-pH 7.47, i-PCO2 38.5, i-PO2 74, i-HCO3 28.2 08/19 CXR impression: Possibly worsening bronchiolitis in the LEFT lower lobe. No convincing bronchopneumonia. Remainder of findings as above 08/20 CXR impression: No acute cardiopulmonary disease. 08/21 ESR result: 23 08/21 FIBRINOGEN result: 384 08/21 DDIMER result: 3.52 08/22 ESR result: 2 08/22 FIBRINOGEN result: 359 08/22 DDIMER result: 3.09 08/23 ESR result: 4 08/23 FIBRINOGEN result: 321 08/23 DDIMER result: 3.46 08/24 ESR result: 15 08/24 SAR-COV-2 IgG result: 2.44 08/24 BNP result: 169.7 08/24 SARS-COV-2 TOTAL AB SPIKE result: >2500.0 08/27 clinically resolved
Her mother noticed a rash forming all over her body; This is a spontaneous report from a contactable reporter (Patient daughter). A 83-year-old-female patient (reporter mother) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry dates were not provided), via an unspecified route of administration, on 20Mar2021, as a single dose for COVID-19 immunisation. Patient medical history and concomitant medications were not reported. It was reported that patient received the second dose of the Pfizer BioNTech COVID-19 vaccine on 20Mar2021 and Yesterday the patient noticed a rash forming all over her body and she would like to know if it is possible that this could be related to the vaccine, even though it has been nearly 4 weeks since she got the dose. Outcome of the event was unknown.   No Follow-up attempts are needed. Information about lot/batch number cannot be obtained.
1030 - Patient complained of itchiness, dry mouth, throat itching. Given water and Benadryl 25mg PO.  Patient reports having multiple allergies with similar reactions.  Patient lying down. BP = 145/87, HR = 79, RR = 18, O2 Sat = 100% 1039 - Patient reports increasing itchiness. BP = 134/66, HR = 71, O2 Sat = 100% 1045 - Patient reports feeling the same. 1057 - Patient talking, reports feeling the same. BP = 130/75, HR = 80, RR = 18, O2 Sat = 100%   Benadryl 25mg PO given. 1108 - Patient reports symptoms improving. 1119 - Symptoms resolved - patient reports no dizziness/sleepiness. BP = 122/80, HR = 74, RR = 17, O2 Sat = 100% 1121 - Patient ambulated with nurse out to reception to check out.
pt recv vax & devel painful induration of 6cm x 5cm @ site;inflammation also of larger area;
Patient went for a routine mammogram screening and was noted to have R axilla lymphadenopathy- likely reactive lymph nodes
Chills; Tired; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Tired) and HEADACHE (Headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 01-Apr-2021, the patient experienced CHILLS (Chills), FATIGUE (Tired) and HEADACHE (Headache). On 02-Apr-2021, CHILLS (Chills) and FATIGUE (Tired) had resolved. At the time of the report, HEADACHE (Headache) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.
Patient received vaccine with no problems, but fainted while watching other family members receive theirs.  Recovered quickly and was checked by our nurse.  Left with family after waiting 15 minutes in the store.
began having tenderness to right side of head with sudden light sensitivity and mild nausea Zofran  4 MG  Take 1 tablet (4 mg total) by mouth every 8 (eight) hours if needed for nausea or vomiting for up to 7 days. MOTRIN 800 MG tablet; Take 1 tablet (800 mg total) by mouth every 8 (eight) hours if needed for moderate pain or headaches for up to 10 days.
This case was reported by a consumer via call center representative and described the occurrence of adverse event in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown. It was unknown if the reporter considered the adverse event to be related to SHINGRIX. Additional details were received as follows: The age at vaccination was not reported. The consumer stated that she received Shingles vaccine and experienced some potential adverse event. When the patient was noticed a call, the patient ended the call abruptly and did not provide any additional details.
Moderna COVID-19 Vaccine EUA (directed to type this on this line) Severe dizziness started at 11:00-45 minutes after time of injection.  Continued until 5:00pm same day; however mild dizziness continues still ( 1/11 @ 9:00am).  Starting 1/9 @ 5:00 flu -like symptoms started (nausea and vomiting, shakes,  weakness) continued until 1/10  am, then lingering light dizziness and weakeness.  As of 1/11 only lingering light dizziness remains.
With in 45 mins I started getting dizzy,nauseous at 2:30 went to work left early 4:30felt I needed to lay down immediately was home at 5:00 passed right out woke 6:30 felt sick by 8 pm I had chills in my bones for 4 hrs I shivered under 3 comforters the first 24 hrs was hell my entire head started pounding headache was9 hrs I couldn't hold my head up 36 hrs no strength ,nauseous .on 3rd day I still feel nauseous to point i can't be stand and function more 10 mins.I would never do this again
fainted morning after shot.; Sore arm; Headache all day; tired; This is a spontaneous report from a contactable consumer reported for self. This 14-year-old patient of unspecified gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot#: Ew0177) at single dose in left arm on 18May2021 16:00 for COVID-19 immunisation. There was no medical history, no allergies. Concomitant medication within 2 weeks of vaccination included cetirizine hydrochloride (ZYRTEC). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19May2021 07:30, patient fainted morning after shot, experienced sore arm, headache all day, tired. There was no treatment received for the events. The reporter considered report as non-serious, not resulted in death, not life threatening, not caused/prolonged hospitalization, not disabling/incapacitating, not congenital anomaly/birth defect. The outcome of events was resolving.   No follow-up attempts are possible. No further information is expected.
pt recv vax & exp breathing diff & rash;tx w/DPh & events resolved;
Rash on face which got worse. Face was puffy, had difficulty breathing and throat "felt funny". Dizziness also, then rash spread to neck and arms. Still has rash today on 4/9/01. No fever, no other symptoms. Had rash after first HBV but less severe. Rash on 4/5/01 at 07:00; SOB on 4/7/01 at 02:00 and saw MD at ER and gave Benadryl.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 35-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the known the information available the Causal relation between the events Drug ineffective, Covid 19 and suspect drug cannot be excluded completely
8 month history of fever; vertigo; frequent falls without injury; miscarriage; allopdynia; right side paresthesias, right neck pain; migratory joint pain; fatigue; back pain that cannot be related to the immunizations she received on 30 Mar 2017.
Fever (102) aches, chills and HA's - 6 hours post injection. Rest and Tylenol and observation in Health Svc.
On 07/23/01, the vacinee received his second dose of Engerix-B and a dose of 7-valent pneumococcal conjugate vaccine (Prevnar; Lederle Labs). Reportedly, two days after receiving Engerix-B, the vaccinee woke up with a high-pitched cry and was taken to the ER. In the ER, LP done results not provided. Reportedly, the vaccinee was admitted to the ICU with "blood infection, red spots on legs". Reportedly, the diagnosis was sepsis. The vaccinee "stayed eight days in th ICU". As of 08/30/01, the events had resolved.
Covid-19; Covid-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Apr2021 as dose 1, single (Lot number: EW0151), in right arm, on 26Apr2021 as dose 2, single (Lot number: ER8735), in right arm, on 03Nov2021 as dose 3 (booster), single (Lot number: 33D26BD), in right arm and on 30Mar2022 as dose 4 (booster), single (Lot number: FP4554), in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Covid+ after stopping treatment (day 11 from start of infection); Negative, notes: two days after testing covid negative; Positive, notes: Covid+ two days after stopping treatment and two days after testing covid negative. It was unknown if therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.
I couldn't enter vaccine type and brand name in 17. It was the recombinanat Zoster vaccine, Shingrix by GSK. Inability to function the day following the vaccine. Severe body aches and sensitivity to touch. Very fatigues. Injection site very sore. Had the same symptoms after the first part of the vaccine was given in October. Could not perform regular activities the day following the injection; remained in bed most of the day. Slept most of the day.
Dose 1 - redness, itching , burning throughout the body - lasted almost till second dose Dose 2 - redness, itching , burning, skin  hypersensitivity, nerve issues in whole body ( tingling, burning), numbness in hands and feet - took 10 days of Benadryl on the schedule per doctor?s advice, now on steroid treatment since all dose 2 reactions are ongoing even after 3 weeks after the vaccine.
Muscles started to shake mildly, 8-10 hrs later.  Next day Severe HEADACHE.  Not pounding, but stiff pressure on both sides of temples.  Treatment was 2  IB motrin,  Slept for an hour and felt GREAT afterward.   By 3 pm I was in great shape, no other issues to report even after 10 hours have past.
Information has been received from a health professional concerning a 25 year old white female teacher with no allergies or medical conditions, who on 29-JUL-2008 at 11:30 am was at the doctors office for an annual exam and was vaccinated intramuscularly into left arm with a second dose of GARDASIL vaccine (yeast) (lot # 0250X). On 29-JUL-2008, approximately 5 minutes after immunization (approximately 11:35 am) the patient experienced fainting and had a head contusion. She was transported to the Emergency department and was released in stable condition. The electrocaridogram and complete blood cell count were performed with normal results. The patient had no illness at the time of vaccination. The patient was feeling better and recovered on 10-JUL-2008.  Additional information is not expected.
Fever of 100+ Fahrenheit. Started after 18 hours, ended by 24 hours. Shortness of breathe and difficulty taking deep breathes. Started after 6 hours, last 48 hours. Enlarged lymph node in my left armpit, with pain.  Started after 12 hours, lasted 96 hours. Intense pain throughout my body, like someone was stabbing me all over my body. Started at 18 hours, lasted to 36 hours. All conditions were treated with 81mg Asprin qd, 1000mg Tylenol q4h. 600mg Ibuprofen q6h
J96.00 ACUTE RESPIRATORY FAILURE 1/20/2021 ACUTE RESPIRATORY FAILURE
Bilateral pulmonary embolism (2). DVT in lower right leg.  Blood work upon entering the hospital (3/26/21 ~ 10 pm) indicated low platelet count  (177).  Heparin drip for 2 days then Xerelto until further notice.
This case was found during archiving activities and has not previously been entered into the global safety database. The case was processed using procedural documents and current labelling documents. This spontaneous report was received from a physician, via a company representative and concerns a male subject of unspecified age: US 9104. The subject's weight, height and medical history were not reported. The subject received typhoid vaccine oral ty21a (capsule, hard, oral, batch 115382A) on 12-MAY-1991 as a prophylactic vaccination. Non-company suspect drugs included: cholera vaccine (injection) as a prophylactic vaccination. Concomitant medications were not reported. On 16-MAY-1991, 07:00, the subject experienced cellulitis, high fever and red eyes. He was hospitalised for 1 day. Cultures (not specified) were taken on an unspecified date, and the results were negative. Action taken with typhoid vaccine oral ty21a and cholera vaccine was unknown. The subject had recovered from cellulitis, high fever and red eyes on an unspecified date. This report was serious (hospitalization).
20 minutes after receiving the flu vaccine, patient began to develop erythema and hives at the site. Patient began to feel swelling in the throat. Patient took a dose of Benadryl.  An ambulance was contacted, and employee was transported by ambulance to medical center. She was evaluated in the ED and discharged to home later in the day. She had a follow up appointment with her primary physician within the week. The allergic reaction to the flu vaccine was annotated in patient's employee medical record. Employee was advised to obtain a medical waiver signed by her primary physician rather than receiving the flu vaccination in the future.
vaccine given at 12:36.  Patient reported feeling hot and dizzy at 12:45. He began shaking & stated he felt weak  BP 253/149 -> was shaking during eval EMS  called at  13:00.  Patient left at 1:14 with EMS HR 89   O2 - 99%
Right arm redden, swollen and warm to touch, denies pain to area, complains of itching. She will take some benadryl when she gets home and apply an ice pack to the area, ibuprofen as needed for discomfort, the patient will come back in 24 hours for us to check the progress of area.
About 5-10 minutes after receiving vaccine, patient became pale and vomited. Vitals were checked: HR 122 BP 115/71 O2Sat 87%. O2Sat was repeated and was again 87-90%. On exam, he was wheezing and had suprasternal retractions.
The next day i had chills, body pain, fatigue, loss of taste, headache, weakness. But on wednesday 3/17/21 i had severe left leg pain from thigh going down, my lower leg got discolored ( darker than my normal color), dizzy, forgetful. Went to ED and my Bp was 185/69- never ever!! Blood test, leg ultrasound normal. Today i still have pain, headache, no appetite. This vaccine is the culprit.
Diarrhea/horrible diarrhea; Flu symptoms, but much worse; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea/horrible diarrhea) and INFLUENZA (Flu symptoms, but much worse) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Serious COVID-19 infection) on 15-Mar-2020. Concurrent medical conditions included Penicillin allergy.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, the patient experienced DIARRHOEA (Diarrhea/horrible diarrhea) and INFLUENZA (Flu symptoms, but much worse). The patient was treated with LOPERAMIDE for Diarrhea, at a dose of 1 dosage form as necessary. On 24-Jul-2021, DIARRHOEA (Diarrhea/horrible diarrhea) had resolved. On 25-Jul-2021, INFLUENZA (Flu symptoms, but much worse) was resolving.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 25-Jul-2021: Follow up information received and contains no Significant Information